CCXIEUR

CHEMOCENTRYX INC

A biopharmaceutical company that developed pill-based medicines for autoimmune and inflammatory diseases, its flagship product being Tavneos (avacopan), an oral treatment for ANCA-associated vasculitis, a rare disease that inflames and destroys small blood vessels. Founded in 1997 by scientist Thomas Schall, the company's name blends "chemo" (for chemokines, the signaling proteins that guide immune cells) with "centryx," a play on "center," reflecting its focus on those pathways. Amgen acquired the company in 2022.